JPWO2020227101A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020227101A5
JPWO2020227101A5 JP2021564995A JP2021564995A JPWO2020227101A5 JP WO2020227101 A5 JPWO2020227101 A5 JP WO2020227101A5 JP 2021564995 A JP2021564995 A JP 2021564995A JP 2021564995 A JP2021564995 A JP 2021564995A JP WO2020227101 A5 JPWO2020227101 A5 JP WO2020227101A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
phenyl
group
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021564995A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022531388A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/031046 external-priority patent/WO2020227101A1/en
Publication of JP2022531388A publication Critical patent/JP2022531388A/ja
Publication of JPWO2020227101A5 publication Critical patent/JPWO2020227101A5/ja
Pending legal-status Critical Current

Links

JP2021564995A 2019-05-03 2020-05-01 Kcnt1阻害剤および使用する方法 Pending JP2022531388A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962842849P 2019-05-03 2019-05-03
US62/842,849 2019-05-03
US202062982864P 2020-02-28 2020-02-28
US62/982,864 2020-02-28
PCT/US2020/031046 WO2020227101A1 (en) 2019-05-03 2020-05-01 Kcnt1 inhibitors and methods of use

Publications (2)

Publication Number Publication Date
JP2022531388A JP2022531388A (ja) 2022-07-06
JPWO2020227101A5 true JPWO2020227101A5 (zh) 2023-05-11

Family

ID=73051241

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021564995A Pending JP2022531388A (ja) 2019-05-03 2020-05-01 Kcnt1阻害剤および使用する方法

Country Status (17)

Country Link
US (1) US20220259193A1 (zh)
EP (1) EP3962481A4 (zh)
JP (1) JP2022531388A (zh)
KR (1) KR20220016086A (zh)
CN (1) CN114269340A (zh)
AU (1) AU2020267356A1 (zh)
BR (1) BR112021022067A2 (zh)
CA (1) CA3139063A1 (zh)
CL (1) CL2021002877A1 (zh)
CO (1) CO2021016471A2 (zh)
EC (1) ECSP21087884A (zh)
IL (1) IL287768A (zh)
MX (1) MX2021013421A (zh)
PE (1) PE20220016A1 (zh)
SA (1) SA521430751B1 (zh)
SG (1) SG11202112158YA (zh)
WO (1) WO2020227101A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202112212WA (en) * 2019-05-03 2021-12-30 Praxis Prec Medicines Inc Kcnt1 inhibitors and methods of use
US20230373937A1 (en) * 2020-09-09 2023-11-23 University Of Virginia Patent Foundation Inhibitors of spinster homolog 2 (spns2) for use in therapy
US11773088B2 (en) 2020-11-02 2023-10-03 Praxis Precision Medicines, Inc. KCNT1 inhibitors and methods of use
WO2022111605A1 (zh) * 2020-11-27 2022-06-02 瑞石生物医药有限公司 芳基或杂芳基取代五元芳杂环化合物及其用途
EP4267133A2 (en) * 2020-12-22 2023-11-01 Praxis Precision Medicines, Inc. Kcnt1 inhibitors and methods of use
WO2022231873A1 (en) * 2021-04-29 2022-11-03 Praxis Precision Medicines, Inc. Kcnt1 inhibitors and methods of use
WO2022231872A1 (en) * 2021-04-29 2022-11-03 Praxis Precision Medicines, Inc. Kcnt1 inhibitors and methods of use
WO2023211850A1 (en) * 2022-04-25 2023-11-02 Praxis Precision Medicines, Inc. Kcnt1 inhibitors comprising an isoxazole or oxadiazole core and methods of use
WO2023239839A1 (en) * 2022-06-08 2023-12-14 Praxis Precision Medicines, Inc. Kcnt1 inhibitors comprising an isoxazole or oxadiazole core and methods of use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4326525A (en) 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US5364620A (en) 1983-12-22 1994-11-15 Elan Corporation, Plc Controlled absorption diltiazem formulation for once daily administration
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5001139A (en) 1987-06-12 1991-03-19 American Cyanamid Company Enchancers for the transdermal flux of nivadipine
US4992445A (en) 1987-06-12 1991-02-12 American Cyanamid Co. Transdermal delivery of pharmaceuticals
US4902514A (en) 1988-07-21 1990-02-20 Alza Corporation Dosage form for administering nilvadipine for treating cardiovascular symptoms
TW200301698A (en) * 2001-12-21 2003-07-16 Bristol Myers Squibb Co Acridone inhibitors of IMPDH enzyme
JP2005060255A (ja) * 2003-08-20 2005-03-10 Nippon Nohyaku Co Ltd カルボキサミド類及びこれを有効成分とする有害生物防除剤
US7585881B2 (en) * 2004-02-18 2009-09-08 Astrazeneca Ab Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
AU2007275221A1 (en) * 2006-07-20 2008-01-24 Allen J. Borchardt Benzothiophene inhibitors of RHO kinase
CA2903979A1 (en) * 2013-03-14 2014-09-18 Novartis Ag 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
US10538516B2 (en) * 2015-03-25 2020-01-21 National Center For Geriatrics And Gerontology Oxadiazole derivative and pharmaceutical containing same
JPWO2017170826A1 (ja) * 2016-03-30 2019-02-14 味の素株式会社 グルカゴン様ペプチド−1受容体作用増強活性を有する化合物
WO2018187480A1 (en) * 2017-04-04 2018-10-11 Praxis Precision Medicines, Inc. Compounds and their methods of use

Similar Documents

Publication Publication Date Title
JP2023144130A5 (zh)
RU2503679C2 (ru) Ингибиторы репликации вируса иммунодефицита человека
JPWO2020227101A5 (zh)
JP2007516983A5 (zh)
JP2011500815A5 (zh)
RU2460730C2 (ru) Новые производные n-(8-гетероарилтетрагидронафталин-2-ил)-или n-(5-гетероарилхроман-3-ил)-карбоксамида для лечения боли
JP2004529140A5 (zh)
JP2006506462A5 (zh)
JP2005514398A5 (zh)
JP2001526269A5 (zh)
JP2017537949A5 (zh)
JP2013501063A5 (zh)
JP2013544860A5 (zh)
WO1997037989A1 (en) Indole derivatives as 5-ht receptor antagonist
CA2966423C (en) Potent gamma-secretase modulators
JP2004532229A5 (zh)
JP2020511547A5 (zh)
EP3994216A1 (en) Antimicrobial dyes for facemasks
AU2019300106B2 (en) Phenyl/pyridyl-n-phenyl/pyridyl derivatives for treating a RNA virus infection
WO2021001445A1 (en) Antimicrobial dyes for healthcare apparel
AU4282900A (en) Heterosubstituted pyridine derivatives as PDE 4 inhibitors
RU2007120691A (ru) Никотинамидопиридинмочевины в качестве ингибиторов киназы рецептора васкулярного эндотелиального фактора роста (vegf)
JPWO2019232209A5 (zh)
JP2006528667A5 (zh)
RU2493150C2 (ru) Соединения 2,4-пиримидиндиаминов и их применение